Showing 851-860 of 2493 results for "".
Cannabinoids and Psychedelics for Headache Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-psychedelics-for-headache-management/32131/Reports of success in self-treatment of primary headache disorders with cannabis and psilocybin have led to clinical trials studying their efficacy and safety.Emerging Therapies for Progressive Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/emerging-therapies-for-progressive-multiple-sclerosis/30125/A number of agents with putative neuroprotective effects have shown promise in recent clinical trials.Vascular Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/vascular-cognitive-impairment/30145/Targeting risk factors may decrease vascular cognitive impairments.Treatment Options for Cranial Neuralgias
https://practicalneurology.com/diseases-diagnoses/headache-pain/treatment-options-for-cranial-neuralgias/30465/A review of treatment and coding options for various cranial neuralgias.Diagnosing And Treating Co-Morbid Sleep Apnea In Neurological Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/diagnosing-and-treating-co-morbid-sleep-apnea-in-neurological-disorders/30843/Since neurologists are frequently principal care providers for many neurological patients, it is crucial for neurology physicians to be familiar with the identification of sleep apnea. First of a two part series.Subarachnoid Hemorrhage, Vasospasm, and Delayed Cerebral Ischemia
https://practicalneurology.com/diseases-diagnoses/stroke/subarachnoid-hemorrhage-vasospasm-and-delayed-cerebral-ischemia/30142/Prevention, effective monitoring, and early detection are the keys to successful management after subarachnoid hemorrhage.Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.Clinical Use of Alzheimer Disease Biomarkers: Legal, Ethical, and Social Considerations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-alzheimer-disease-biomarkers-legal-ethical-and-social-considerations/32141/Legal, ethical, and social considerations are emerging along with the clinical implementation of Alzheimer disease biomarkers.Diagnosis and Treatment of Neuro-Ophthalmologic Symptoms in People with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-treatment-of-neuro-ophthalmologic-symptoms-in-people-with-parkinson-disease/37656/Recognizing and addressing neuro-ophthalmologic signs and symptoms are essential for delivering comprehensive, patient-centered care and improving long-term outcomes in individuals with PD.Case Report: Hemiparkinsonism in a Patient With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/movement-disorders/case-report-hemiparkinsonism-in-a-patient-with-multiple-sclerosis/31527/In this case, there was a causal relationship between comorbid diseases.